At this time, posts about Helixmith are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 39,000 shares today. Helixmith is known as a company specializing in new drug development focused on gene therapy.


As of 11:30 AM on the 21st, Helixmith's stock price is 37,600 KRW, down 10.05% from the previous day, with a trading volume of 2,145,067 shares, which is 102.08% of the 5-day average trading volume. On September 18, Helixmith became an issue in the market with the news of a "280 billion KRW scale paid-in capital increase causing a 16% drop."


In addition to Helixmith, posts by investors are also rapidly increasing for companies such as Silla Textile (001000), HL Biopower (043220), and Andyforce (238090).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing